In situ formation of antimicrobial silver nanoparticles and the impregnation of hydrophobic polycaprolactone matrix for antimicrobial medical device applications

Materials Science and Engineering C

Volumn 47, Issue , 2015, Pages 63-69

  Tran, Phong A ^a   Hocking, Dianna M ^a   O'Connor, Andrea J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antimicrobial; Hydrophobic polymers; Medical devices; Nanoparticles

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; BACTERIA; BIOMEDICAL EQUIPMENT; FUNCTIONAL POLYMERS; HYDROPHILICITY; HYDROPHOBICITY; IMPREGNATION; MATERIALS PROPERTIES; NANOPARTICLES; POLYCAPROLACTONE;

ANTIBIOTIC TREATMENT; ANTIMICROBIAL; ANTIMICROBIAL SILVERS; BACTERIAL INFECTIONS; GRAM-POSITIVE PATHOGENS; HYDROPHOBIC POLYMERS; MEDICAL DEVICES; SILVER NANOPARTICLES;

SILVER;

ANTIINFECTIVE AGENT; METAL NANOPARTICLE; POLYCAPROLACTONE; POLYESTER; SILVER;

ANIMAL; BIOFILM; CHEMICAL PHENOMENA; CHEMISTRY; DEVICES; DRUG EFFECTS; INFRARED SPECTROSCOPY; MICROBIAL SENSITIVITY TEST; MOUSE; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; X RAY PHOTOELECTRON SPECTROSCOPY;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOFILMS; EQUIPMENT AND SUPPLIES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; METAL NANOPARTICLES; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; PHOTOELECTRON SPECTROSCOPY; POLYESTERS; PSEUDOMONAS AERUGINOSA; SILVER; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAPHYLOCOCCUS AUREUS;

EID: 84911935718     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2014.11.016     Document Type: Article

References (21)

1. R.D. Scott, The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention, Division of Healthcare Quality Promotion National Center for Preparedness, Detection, and Control of Infectious Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention (March 2009) Available at http://www.cdc.gov/ncidod/dhqp/pdf/Scott-CostPaper.pdf.
2. A.J. Huh, Y.J. Kwon, "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era, J. Control. Release 156 (2) (2011) 128-145.
3. Z.-M. Xiu, J. Ma, P.J. Alvarez, Differential effect of common ligands and molecular oxygen on antimicrobial activity of silver nanoparticles versus silver ions, Environ. Sci. Technol. 45 (20) (2011) 9003-9008.
4. B.S. Atiyeh, et al., Effect of silver on burn wound infection control and healing: review of the literature, Burns 33 (2) (2007) 139-148.
5. M. Auffan, et al., Chemical stability ofmetallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro, Environ. Pollut. 157 (4) (2009) 1127-1133.
6. J.A. Spadaro, et al., Antibacterial effects of silver electrodes with weak direct current, Antimicrob. Agents Chemother. 6 (5) (1974) 637-642.
7. Q.L. Feng, et al., A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus, J. Biomed. Mater. Res. 52 (4) (2000) 662-668.
8. P.D. Bragg, D.J. Rainnie, The effect of silver ions on the respiratory chain of Escherichia coli, Can. J. Microbiol. 20 (6) (1974) 883-889.
9. +, Biochemistry 44 (39) (2005) 13214-13223.
10. A. Ludwicka, et al., Attachment of staphylococci to various synthetic-polymers, Zentralbl. Bakteriol. Mikrobiol. Hyg. A Med. Microbiol. Infect. Dis. Virol. Parasitol. 256 (4) (1984) 479-489.
11. Y.H. An, R.J. Friedman, Concise review of mechanisms of bacterial adhesion to biomaterial surfaces, J. Biomed. Mater. Res. 43 (3) (1998) 338-348.
12. C. Petit, P. Lixon, M.P. Pileni, In situ synthesis of silver nanocluster in AOT reverse micelles, J. Phys. Chem. 97 (49) (1993) 12974-12983.
13. R.V. Madhavan, et al., Silver nanoparticle impregnated poly (epsilon-caprolactone) scaffolds: optimization of antimicrobial and noncytotoxic concentrations, Tissue Eng. A 17 (3-4) (2011) 439-449.
14. F.C. Tenover, et al., Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides, J. Clin. Microbiol. 36 (4) (1998) 1020-1027.
15. M.V. Berridge, A.S. Tan, Characterization of the cellular reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction, Arch. Biochem. Biophys. 303 (2) (1993) 474-482.
16. S.-Y. Ong, et al., Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties, Biomaterials 29 (32) (2008) 4323-4332.
17. H. Song, et al., Fabrication of silver nanoparticles and their antimicrobial mechanisms, Eur. Cell Mater. 11 (Suppl. 1) (2006) 58.
18. J. Costerton, P.S. Stewart, E. Greenberg, Bacterial biofilms: a common cause of persistent infections, Science 284 (5418) (1999) 1318-1322.
19. P.S. Stewart, J. William Costerton, Antibiotic resistance of bacteria in biofilms, Lancet, 2001. 358 (9276): p. 135-138.
20. R.M. Donlan, Biofilms and device-associated infections, Emerg. Infect. Dis. 7 (2) (2001) 277.
21. Z. Bendouah, et al., Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis, Otolaryngol. Head Neck Surg. 134 (6) (2006) 991-996.